Appointment part of company’s ambitious global growth strategy CN Bio, one of the world’s leading Organ-on-a-Chip companies has appointed Dr Samantha Macro as Chief Financial Officer. Dr Macro joins CEO, Dr Paul Brooks, on the executive board to guide key commercial and strategic initiatives, increase revenue and shape the company’s growth trajectory.
Avacta Group has acquired Coris Bioconcept for £7.4 million and an extra £3 million payout based on future business performance.
Integrative solutions at the speed of life
The Intelligent Analyzer
EASY. EFFICIENT. EXCEPTIONAL. Fully automated IIFT from primary sample to fi nal result
Patients with acute respiratory distress syndrome (ARDS) are particularly vulnerable to adverse effects of fluid overload. Plasma volume status (PVS), defined as the percentage deviation from ideal plasma volume, has emerged as a rapid, noninvasive method to assess volume status and prognosis:1
Simple. Efficient. Versatile.
Due to automated sample preparation, our new CLAM-2040 makes analysis easier and more efficient than ever before – perfect also for less experienced users.
HDL-c direct FS LDL-c direct FS
Scientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.